Autologous TAC T Cells Targeting CD19 in R/R Large B-Cell Lymphoma
Clinical trial NCT03880279 · WITHDRAWN
Trial details
- NCT number
- NCT03880279
- Sponsor
- Triumvira Immunologics, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2022-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.